Asset Details
Do you wish to reserve the book?
Management of infections related to totally implantable venous-access ports: challenges and perspectives
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Management of infections related to totally implantable venous-access ports: challenges and perspectives
Do you wish to request the book?
Management of infections related to totally implantable venous-access ports: challenges and perspectives
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Management of infections related to totally implantable venous-access ports: challenges and perspectives
2014
Overview
Use of totally implantable venous-access ports (TIVAPs) is standard practice for patients with diseases such as solid-tumour cancers, haematological malignancies, and chronic digestive diseases. Use of TIVAPs allows long-term administration of venotoxic compounds, improves patients' quality of life, and reduces the risk of infection. Microbial contamination, formation of pathogenic biofilms, and infection, however, are associated with morbidity, mortality, and increased health-care costs. Local and systemic complications or infections related to specific pathogens might lead to device removal. Alternatively, conservative treatment with combined systemic antibiotics and antibiotic lock therapy might be useful. We discuss in-vitro and in-vivo basic and clinical research findings on the epidemiology, diagnosis, and prevention of TIVAP-related infections, the current challenges to management, promising strategies, and some treatments in development that are likely to improve outcomes of TIVAP-related infections, with a particular focus on antibiotic lock therapy.
Publisher
Elsevier Ltd,Lancet Publishing Group,Elsevier Limited,New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001
Subject
Anti-Bacterial Agents - therapeutic use
/ Bacteria
/ Biofilms
/ Biological and medical sciences
/ Catheter-Related Infections - diagnosis
/ Catheter-Related Infections - etiology
/ Catheter-Related Infections - therapy
/ Catheterization, Central Venous - instrumentation
/ Catheterization, Central Venous - methods
/ Catheters, Indwelling - adverse effects
/ Humans
/ Microbiology and Parasitology
/ Public health. Hygiene-occupational medicine
/ Skin
